As mentioned above, in previous studies, we demonstrated that uPA is overexpressed in HCC and that it is a responsive therapeutic target since its inhibition provoked a decrease of HCC cellular migration and invasion (25,35–37). This evidence concerns the gene PLAU and hepatocellular carcinoma.